bioRxivPharmacology & Toxicology
Structural Analysis of Genomic and Proteomic Signatures Reveal Dynamic Expression of Intrinsically Disordered Regions in Breast Cancer and Tissue
N. Zatorski, Y. Sun, A. Elmas, C. Dallago, T. Karl, D. Stein, B. Rost, K.-L. Huang, M. Walsh, A. Schlessinger
Abstract
Structural features of proteins capture underlying information about protein evolution and function, which enhances the analysis of proteomic and transcriptomic data. Here we develop Structural Analysis of Gene and protein Expression Signatures (SAGES), a method that describes expression data using features calculated from sequence-based prediction methods and 3D structural models. We used SAGES, along with machine learning, to characterize tissues from healthy individuals and those with breast cancer. We analyzed gene expression data from 23 breast cancer patients and genetic mutation data from the COSMIC database as well as 17 breast tumor protein expression profiles. We identified prominent expression of intrinsically disordered regions in breast cancer proteins as well as relationships between drug perturbation signatures and breast cancer disease signatures. Our results suggest that SAGES is generally applicable to describe diverse biological phenomena including disease states and drug effects.
- organism: human
- assay: proteomics
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: drug response / drug discovery
- research focus: differential expression
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteome-wide signatures of function in highly diverged intrinsically disordered regions
Taraneh Zarin, Bob Strome, … Alan M Moses·eLifePeer-reviewed·Jul 2, 2019
- Signaling Pathway Activities Improve Prognosis for Breast Cancer
Yunlong Jiao, Marta R. Hidalgo, … Joaquı́n Dopazo·bioRxiv·Apr 29, 2017
- How mutations of intrinsically disordered protein regions can drive cancer
Bálint Mészáros, Borbála Hajdu-Soltész, … Zsuzsanna Dosztányi·bioRxiv·Apr 29, 2020
- Prelude to Malignancy: A Gene Expression Signature in Normal Mammary Gland from Breast Cancer Patients Suggests Pre-tumorous Alterations and Is Associated with Adverse Outcomes
Maria Andreou, Marcin Jąkalski, … Arkadiusz Piotrowski·International Journal of CancerPeer-reviewed·Jun 8, 2024
- Pathway-Level Integration of Proteogenomic data in Breast Cancer Using Independent Component Analysis
Wenke Liu, Sisi Ma, David Fenyö·bioRxiv·Aug 13, 2017
- A Proteogenomic workflow reveals distinct molecular phenotypes related to breast cancer appearance
Tommaso De Marchi, Paul Theodor Pyl, … Emma Niméus·bioRxiv·May 5, 2020